These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
403 related items for PubMed ID: 18940256
1. Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy. del Pozo-Rodríguez A, Solinís MA, Gascón AR, Pedraz JL. Eur J Pharm Biopharm; 2009 Feb; 71(2):181-9. PubMed ID: 18940256 [Abstract] [Full Text] [Related]
2. Optimization of the lyophilization process for long-term stability of solid-lipid nanoparticles. Howard MD, Lu X, Jay M, Dziubla TD. Drug Dev Ind Pharm; 2012 Oct; 38(10):1270-9. PubMed ID: 22235767 [Abstract] [Full Text] [Related]
3. Development of lyophilized gemini surfactant-based gene delivery systems: influence of lyophilization on the structure, activity and stability of the lipoplexes. Mohammed-Saeid W, Michel D, El-Aneed A, Verrall RE, Low NH, Badea I. J Pharm Pharm Sci; 2012 Oct; 15(4):548-67. PubMed ID: 23106958 [Abstract] [Full Text] [Related]
4. Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization. Heiati H, Tawashi R, Phillips NC. J Microencapsul; 1998 Oct; 15(2):173-84. PubMed ID: 9532523 [Abstract] [Full Text] [Related]
5. pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles. Vighi E, Ruozi B, Montanari M, Battini R, Leo E. Int J Pharm; 2010 Apr 15; 389(1-2):254-61. PubMed ID: 20100555 [Abstract] [Full Text] [Related]
6. Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells. Choi SH, Jin SE, Lee MK, Lim SJ, Park JS, Kim BG, Ahn WS, Kim CK. Eur J Pharm Biopharm; 2008 Mar 15; 68(3):545-54. PubMed ID: 17881199 [Abstract] [Full Text] [Related]
7. Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology. Teeranachaideekul V, Junyaprasert VB, Souto EB, Müller RH. Int J Pharm; 2008 Apr 16; 354(1-2):227-34. PubMed ID: 18242898 [Abstract] [Full Text] [Related]
8. Effect of freeze-drying, cryoprotectants and storage conditions on the stability of secondary structure of insulin-loaded solid lipid nanoparticles. Soares S, Fonte P, Costa A, Andrade J, Seabra V, Ferreira D, Reis S, Sarmento B. Int J Pharm; 2013 Nov 18; 456(2):370-81. PubMed ID: 24036086 [Abstract] [Full Text] [Related]
9. Solid lipid nanoparticles for retinal gene therapy: transfection and intracellular trafficking in RPE cells. del Pozo-Rodríguez A, Delgado D, Solinís MA, Gascón AR, Pedraz JL. Int J Pharm; 2008 Aug 06; 360(1-2):177-83. PubMed ID: 18508211 [Abstract] [Full Text] [Related]
10. Effect of sugars on storage stability of lyophilized liposome/DNA complexes with high transfection efficiency. Maitani Y, Aso Y, Yamada A, Yoshioka S. Int J Pharm; 2008 May 22; 356(1-2):69-75. PubMed ID: 18249511 [Abstract] [Full Text] [Related]
11. Development of a lyophilized plasmid/LPEI polyplex formulation with long-term stability--A step closer from promising technology to application. Kasper JC, Schaffert D, Ogris M, Wagner E, Friess W. J Control Release; 2011 May 10; 151(3):246-55. PubMed ID: 21223985 [Abstract] [Full Text] [Related]
12. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients. Anhorn MG, Mahler HC, Langer K. Int J Pharm; 2008 Nov 03; 363(1-2):162-9. PubMed ID: 18672043 [Abstract] [Full Text] [Related]
13. Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid. Vighi E, Ruozi B, Montanari M, Battini R, Leo E. Eur J Pharm Biopharm; 2007 Sep 03; 67(2):320-8. PubMed ID: 17368876 [Abstract] [Full Text] [Related]
14. Survival of Brucella abortus strain RB51 lyophilized and as liquid vaccine under different storage conditions. Capsel RL, Olsen SC, Cheville NF, Thoen CO. Biologicals; 2000 Dec 03; 28(4):209-15. PubMed ID: 11237356 [Abstract] [Full Text] [Related]
15. A proline-rich peptide improves cell transfection of solid lipid nanoparticle-based non-viral vectors. del Pozo-Rodríguez A, Pujals S, Delgado D, Solinís MA, Gascón AR, Giralt E, Pedraz JL. J Control Release; 2009 Jan 05; 133(1):52-9. PubMed ID: 18854203 [Abstract] [Full Text] [Related]
16. Arginine-chitosan/DNA self-assemble nanoparticles for gene delivery: In vitro characteristics and transfection efficiency. Gao Y, Xu Z, Chen S, Gu W, Chen L, Li Y. Int J Pharm; 2008 Jul 09; 359(1-2):241-6. PubMed ID: 18479851 [Abstract] [Full Text] [Related]
17. A systematic study on lyophilization process of polymersomes for long-term storage using doxorubicin-loaded (PEG)₃-PLA nanopolymersomes. Ayen WY, Kumar N. Eur J Pharm Sci; 2012 Aug 15; 46(5):405-14. PubMed ID: 22465658 [Abstract] [Full Text] [Related]
18. Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery. Yu W, Liu C, Ye J, Zou W, Zhang N, Xu W. Nanotechnology; 2009 May 27; 20(21):215102. PubMed ID: 19423923 [Abstract] [Full Text] [Related]
19. Investigation on formulation and preparation of adenovirus encoding human endostatin lyophilized powders. Chen S, Guo D, Guo B, Liu J, Shen Y, Xu X, Huang W, Guo S. Int J Pharm; 2012 May 10; 427(2):145-52. PubMed ID: 22234038 [Abstract] [Full Text] [Related]
20. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid. Attama AA, Müller-Goymann CC. Int J Pharm; 2007 Apr 04; 334(1-2):179-89. PubMed ID: 17140752 [Abstract] [Full Text] [Related] Page: [Next] [New Search]